The δ opioid receptor agonist SNC80 selectively activates heteromeric μ-δ Opioid receptors

Matthew D. Metcalf, Ajay S. Yekkirala, Michael D. Powers, Kelley F Kitto, Carolyn A Fairbanks, George L Wilcox, Philip S Portoghese

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Coexpressed and colocalized μ- and δ-opioid receptors have been established to exist as heteromers in cultured cells and in vivo. However the biological significance of opioid receptor heteromer activation is less clear. To explore this significance, the efficacy of selective activation of opioid receptors by SNC80 was assessed in vitro in cells singly and coexpressing opioid receptors using a chimeric G-protein-mediated calcium fluorescence assay, SNC80 produced a substantially more robust response in cells expressing μ-δ heteromers than in all other cell lines. Intrathecal SNC80 administration in μ- and δ-opioid receptor knockout mice produced diminished antinociceptive activity compared with wild type. The combined in vivo and in vitro results suggest that SNC80 selectively activates μ-δ heteromers to produce maximal antinociception. These data contrast with the current view that SNC80 selectively activates δ-opioid receptor homomers to produce antinociception. Thus, the data suggest that heteromeric μ-δ receptors should be considered as a target when SNC80 is employed as a pharmacological tool in vivo.

Original languageEnglish (US)
Pages (from-to)505-509
Number of pages5
JournalACS Chemical Neuroscience
Volume3
Issue number7
DOIs
StatePublished - Jul 18 2012

Fingerprint

Opioid Receptors
Cells
Chemical activation
GTP-Binding Proteins
Knockout Mice
4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide
Cultured Cells
Assays
Fluorescence
Pharmacology
Calcium
Cell Line

Keywords

  • SNC80
  • antinociception
  • knockout
  • δ opioid receptor
  • μ opioid receptor
  • μ-δheteromer

Cite this

The δ opioid receptor agonist SNC80 selectively activates heteromeric μ-δ Opioid receptors. / Metcalf, Matthew D.; Yekkirala, Ajay S.; Powers, Michael D.; Kitto, Kelley F; Fairbanks, Carolyn A; Wilcox, George L; Portoghese, Philip S.

In: ACS Chemical Neuroscience, Vol. 3, No. 7, 18.07.2012, p. 505-509.

Research output: Contribution to journalArticle

@article{9f2adc71bb544007aaf3bdb5cdbcfc6e,
title = "The δ opioid receptor agonist SNC80 selectively activates heteromeric μ-δ Opioid receptors",
abstract = "Coexpressed and colocalized μ- and δ-opioid receptors have been established to exist as heteromers in cultured cells and in vivo. However the biological significance of opioid receptor heteromer activation is less clear. To explore this significance, the efficacy of selective activation of opioid receptors by SNC80 was assessed in vitro in cells singly and coexpressing opioid receptors using a chimeric G-protein-mediated calcium fluorescence assay, SNC80 produced a substantially more robust response in cells expressing μ-δ heteromers than in all other cell lines. Intrathecal SNC80 administration in μ- and δ-opioid receptor knockout mice produced diminished antinociceptive activity compared with wild type. The combined in vivo and in vitro results suggest that SNC80 selectively activates μ-δ heteromers to produce maximal antinociception. These data contrast with the current view that SNC80 selectively activates δ-opioid receptor homomers to produce antinociception. Thus, the data suggest that heteromeric μ-δ receptors should be considered as a target when SNC80 is employed as a pharmacological tool in vivo.",
keywords = "SNC80, antinociception, knockout, δ opioid receptor, μ opioid receptor, μ-δheteromer",
author = "Metcalf, {Matthew D.} and Yekkirala, {Ajay S.} and Powers, {Michael D.} and Kitto, {Kelley F} and Fairbanks, {Carolyn A} and Wilcox, {George L} and Portoghese, {Philip S}",
year = "2012",
month = "7",
day = "18",
doi = "10.1021/cn3000394",
language = "English (US)",
volume = "3",
pages = "505--509",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - The δ opioid receptor agonist SNC80 selectively activates heteromeric μ-δ Opioid receptors

AU - Metcalf, Matthew D.

AU - Yekkirala, Ajay S.

AU - Powers, Michael D.

AU - Kitto, Kelley F

AU - Fairbanks, Carolyn A

AU - Wilcox, George L

AU - Portoghese, Philip S

PY - 2012/7/18

Y1 - 2012/7/18

N2 - Coexpressed and colocalized μ- and δ-opioid receptors have been established to exist as heteromers in cultured cells and in vivo. However the biological significance of opioid receptor heteromer activation is less clear. To explore this significance, the efficacy of selective activation of opioid receptors by SNC80 was assessed in vitro in cells singly and coexpressing opioid receptors using a chimeric G-protein-mediated calcium fluorescence assay, SNC80 produced a substantially more robust response in cells expressing μ-δ heteromers than in all other cell lines. Intrathecal SNC80 administration in μ- and δ-opioid receptor knockout mice produced diminished antinociceptive activity compared with wild type. The combined in vivo and in vitro results suggest that SNC80 selectively activates μ-δ heteromers to produce maximal antinociception. These data contrast with the current view that SNC80 selectively activates δ-opioid receptor homomers to produce antinociception. Thus, the data suggest that heteromeric μ-δ receptors should be considered as a target when SNC80 is employed as a pharmacological tool in vivo.

AB - Coexpressed and colocalized μ- and δ-opioid receptors have been established to exist as heteromers in cultured cells and in vivo. However the biological significance of opioid receptor heteromer activation is less clear. To explore this significance, the efficacy of selective activation of opioid receptors by SNC80 was assessed in vitro in cells singly and coexpressing opioid receptors using a chimeric G-protein-mediated calcium fluorescence assay, SNC80 produced a substantially more robust response in cells expressing μ-δ heteromers than in all other cell lines. Intrathecal SNC80 administration in μ- and δ-opioid receptor knockout mice produced diminished antinociceptive activity compared with wild type. The combined in vivo and in vitro results suggest that SNC80 selectively activates μ-δ heteromers to produce maximal antinociception. These data contrast with the current view that SNC80 selectively activates δ-opioid receptor homomers to produce antinociception. Thus, the data suggest that heteromeric μ-δ receptors should be considered as a target when SNC80 is employed as a pharmacological tool in vivo.

KW - SNC80

KW - antinociception

KW - knockout

KW - δ opioid receptor

KW - μ opioid receptor

KW - μ-δheteromer

UR - http://www.scopus.com/inward/record.url?scp=84863911212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863911212&partnerID=8YFLogxK

U2 - 10.1021/cn3000394

DO - 10.1021/cn3000394

M3 - Article

VL - 3

SP - 505

EP - 509

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 7

ER -